Stock Price Quote

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1777.65-58.15 (-3.17 %)
PREV CLOSE ( ) 1835.80
OPEN PRICE ( ) 1790.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3253
TODAY'S LOW / HIGH ( )1730.00 1805.10
52 WK LOW / HIGH ( )1246.75 3375.45
NSE1769.20-58 (-3.17 %)
PREV CLOSE( ) 1827.20
OPEN PRICE ( ) 1788.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1769.20 (8)
VOLUME 47374
TODAY'S LOW / HIGH( ) 1730.55 1824.00
52 WK LOW / HIGH ( )1242.95 3379
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987
Management Info
Bhupendra V Gandhi - Chairman Rajiv Gandhi - Managing Director
Registered Office

Address Meda Adraj , Kadi, , ,
Mehsana,
Gujarat-384441

Phone 079 – 26445106

Email mail@hester.in

Website www.hester.in

Registrars Details
MUFG Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE

NEWS

26Mar Hester Biosciences informs about tradi
Hester Biosciences has informed that pursuant SEBI (Prohibition of Insid..
23Jan Hester Biosciences informs about earni
Hester Biosciences has informed that, as per Regulation 30 of the SEBI (..
22Jan Hester Biosciences informs about board
Hester Biosciences has informed that, as per Regulation 29 of the SEBI (..
14Jan Hester Biosciences informs about newsp
In compliance of Regulation 30 of Securities and Exchange Board of India..
06Jan Hester Biosciences informs about cert
Hester Biosciences has informed that the name of the RTA of the Company..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit44.39271.59
Gross Profit 64.91 367.32
Operating Profit 103.17516.03
Net Sales 628.262851.55

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  3284.75 (1.08%)
M.Cap ( in Cr)111170.87
Mankind Pharma (BSE)
peergroup  2450.40 (0.93%)
M.Cap ( in Cr)101098.24
Bal Pharma (BSE)
peergroup  121.70 (11.61%)
M.Cap ( in Cr)193.81
Sanofi India (BSE)
peergroup  6011.35 (0.19%)
M.Cap ( in Cr)13844.51
Source Natural Foods (BSE)
peergroup  193.95 (3.11%)
M.Cap ( in Cr)124.84

Shareholding Pattern

PROMOTERS 53.73%
NON-INSTITUTION 45.67%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Hester Biosciences Ltd.

Hester Biosciences Ltd. was incorporated in the year 1987. Its today's share price is 1777.65. Its current market capitalisation stands at Rs 1512.22 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2853.88 Cr and Total Income of Rs.2899.07 Cr. The company's management includes Bhupendra V Gandhi, Nina Gandhi, Ravin Gandhi, Sanjiv Gandhi, Priya Gandhi, Vinod Mali, Jatin Trivedi, Anil Jain, Ameet Desai, Ashok Bhadakal, Sandhya Patel, Rajiv Gandhi.

It is listed on the BSE with a BSE Code of 524669 , NSE with an NSE Symbol of HESTERBIO and ISIN of INE782E01017. It's Registered office is at Meda Adraj , Kadi, , Mehsana-384441, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Apaji Amin & Co LLP, Chandulal M Shah & Co, Shah Karia & Associates, Shah Narielwala & Co

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.